Care of patients with hepatitis C and HIV co-infection

AIDS. 2004 Jan 2;18(1):1-12. doi: 10.1097/00002030-200401020-00001.
No abstract available

Publication types

  • Editorial
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Anti-Retroviral Agents / adverse effects
  • Anti-Retroviral Agents / therapeutic use
  • Antiviral Agents / adverse effects
  • Antiviral Agents / therapeutic use*
  • HIV Infections / complications*
  • HIV Infections / drug therapy
  • HIV Seropositivity / complications
  • HIV Seropositivity / drug therapy
  • Hepatitis C / complications
  • Hepatitis C / drug therapy*
  • Hepatitis C / surgery
  • Humans
  • Interferon alpha-2
  • Interferon-alpha / adverse effects
  • Interferon-alpha / therapeutic use
  • Liver Transplantation
  • Polyethylene Glycols / adverse effects
  • Polyethylene Glycols / therapeutic use
  • Recombinant Proteins
  • Ribavirin / adverse effects
  • Ribavirin / therapeutic use
  • Treatment Outcome

Substances

  • Anti-Retroviral Agents
  • Antiviral Agents
  • Interferon alpha-2
  • Interferon-alpha
  • Recombinant Proteins
  • Polyethylene Glycols
  • Ribavirin
  • peginterferon alfa-2a